US Stock MarketDetailed Quotes

Rigel Pharmaceuticals (RIGL)

Watchlist
  • 47.240
  • -0.040-0.08%
Close Sep 11 16:00 ET
  • 47.240
  • 0.0000.00%
Post 19:30 ET
882.44MMarket Cap2.80P/E (TTM)

About Rigel Pharmaceuticals Company

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Company Profile

SymbolRIGL
Company NameRigel Pharmaceuticals
Listing DateNov 29, 2000
Issue Price7.00
ISINUS7665597024
Founded1996
CEOMr. Raul R. Rodriguez
MarketNASDAQ
Employees174
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1985
Phone1-650-624-1100

Company Executives

  • Name
  • Position
  • Salary
  • Raul R. Rodriguez
  • President, Director and Chief Executive Officer
  • 4.66M
  • Lisa Rojkjaer
  • Executive Vice President and Chief Medical Officer
  • 1.83M
  • Raymond J. Furey
  • Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
  • 1.77M
  • Dean L. Schorno
  • Executive Vice President and Chief Financial Officer
  • 1.82M
  • David A. Santos
  • Executive Vice President and Chief Commercial Officer
  • 1.83M
  • Gregg Anthony Lapointe, C.P.A.,M.B.A.
  • Chairman of the Board
  • 217.77K
  • Michael P. Miller
  • Independent Director
  • --
  • Kamil Ali-Jackson, Esq.
  • Independent Director
  • 167.77K
  • Jane Wasman, J.D.
  • Independent Director
  • 172.77K
  • Dr. Walter H. Moos,PhD
  • Independent Director
  • 165.77K
  • Dr. Mark W. Frohlich M.D.
  • Independent Director
  • 288.62K
  • Dr. Alison L. Hannah, M.D.
  • Independent Director
  • 165.77K